Emergent Biosolutions reported $169.8M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 2.67M 0.28M
Akebia Therapeutics AKBA:US $ 10.48M 12.54M
Alnylam Pharmaceuticals ALNY:US $ 40.81M 5.18M
Amarin AMRN:US $ 35.81M 13.57M
Ani Pharmaceuticals ANIP:US $ 35.29M 1.02M
Biomarin Pharmaceutical BMRN:US $ 123.13M 6.16M
Chimerix CMRX:US 0 114K
Coherus Biosciences CHRS:US $ 11.28M 1.91M
Emergent Biosolutions EBS:US $ 169.8M 13.9M
Exact Sciences EXAS:US $ 144.6M 9.9M
Exelixis EXEL:US $ 13.48M 0.28M
Glaxosmithkline GSK:US $ 2136M 1509M
Heron Therapeutics HRTX:US $ 16.18M 4.82M
Intercept Pharmaceuticals ICPT:US $ 0.31M 0.45M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Lonza Group LONN:SW 1.79B 14M
Merk MRK:US $ 3698M 1636M
Moderna Inc MRNA:US 1.38B 364M
Myriad Genetics MYGN:US $ 49.7M 1.7M
Nektar Therapeutics NKTR:US $ 5.12M 0.2M
Neurocrine Biosciences NBIX:US $ 4.8M 0.2M
Opko Health OPK:US $ 194.31M 49.56M
Pacira Pharmaceuticals PCRX:US $ 50.63M 14.55M
Pfizer PFE:US $ 8671M 1339M
Ptc Therapeutics PTCT:US $ 9.64M 0.5M
Sarepta Therapeutics SRPT:US $ 37.8M 6.35M
Seattle Genetics SGEN:US $ 106.1M 18.47M
Teva Pharmaceutical Industries TEVA:US $ 1958M 99M
United Therapeutics UTHR:US $ 29.7M 3.8M
Vanda Pharmaceuticals VNDA:US $ 6.06M 0.39M